Related Experiment Video
Updated: Mar 10, 2026

09:45
Detection of Copy Number Alterations Using Single Cell Sequencing
Published on: February 17, 2017
12.2K
ascatNgs: Identifying Somatically Acquired Copy-Number Alterations from Whole-Genome Sequencing Data
Keiran M Raine1, Peter Van Loo1,2, David C Wedge1,3
1Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
Current Protocols in Bioinformatics
|December 9, 2016
Summary
Researchers can now more easily perform Allele-Specific Copy number Analysis of Tumours (ASCAT) with ascatNgs. This new tool suite simplifies handling complex file types and supports various computational approaches for tumor DNA analysis.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Research
Background:
- Allele-Specific Copy number Analysis of Tumours (ASCAT) is crucial for understanding tumor genome alterations.
- ASCAT identifies DNA copy number changes and estimates Aberrant Cell Fraction (ACF).
- The ASCAT R-package requires extensive file management, posing a challenge for researchers.
Purpose of the Study:
- To introduce ascatNgs, a novel suite of tools designed to streamline the ASCAT workflow.
- To simplify the generation and handling of necessary file types for ASCAT analysis.
- To provide flexible computational approaches for both individual and large-scale tumor genome analyses.
Main Methods:
- Development of a user-friendly tool suite, ascatNgs.
- Integration of functionalities for handling ASCAT-required file types.
- Implementation of 'one-shot' execution and scalable solutions for compute farms.
Main Results:
- ascatNgs facilitates easier implementation of ASCAT for tumor DNA analysis.
- The tool suite simplifies complex data handling, reducing user burden.
- Code is publicly available on GitHub, promoting accessibility and collaboration.
Conclusions:
- ascatNgs significantly enhances the usability of ASCAT for researchers.
- The developed tools support diverse research needs, from single samples to large cohorts.
- This contributes to advancing cancer genomics research through improved analytical pipelines.

